TrialTherapeutic advances in respiratory disease

The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis.

Grace Hyun J Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.